Page results
-
The Secretary of State for Health and Social Care Sajid Javid visited the UCLH vaccination centre at UCL’s Bidborough House on Thursday 23 September to see the vital role UCLH and UCL are playing in getting the UK’s population vaccinated for COVID-19.
-
Contact the Patient Advice and Liaison Service (PALS)
-
Freedom of Information request
-
Read more about the award for researcher behind first treatment for rare disease
-
We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care 8.7 out of 10. This is an improvement on our 2021 score and the highest score of any acute/combined trust in England.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
The psychology team at UCLH will be running a 'Navigating the exam period' workshop on Thursday 26 October 2023, 10am - 1pm, at UCLH.
-
This page explains what Post-COVID-19 Syndrome is.
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
File results
-
FOI/2024/0697 - Autism spectrum disorder (ASD)/ attention deficit hyperactivity disorder (ADHD) and mental health services
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024
-
FOI/2024/0685 - Lunch/ dinner menus for patients
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma